Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 23
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Platelet clinical best practices | Romans R | 2019 | Blood.ca website | View Platelet clinical best practices | Health care providers | Benchmarking and standard setting |
Surveillance Report 2018 | O'Brien S | 2019 | Blood.ca website | View Surveillance Report 2018 | Health care providers | Benchmarking and standard setting |
Immunotherapy: the good, the bad, the ugly, and the really ugly | Branch DR | 2019 | Transfusion | View Immunotherapy: the good, the bad, the ugly, and the really ugly | Researchers | Clinical research |
An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia | Eekels JJM, Althaus K, Bakchoul T, Kroll H, Kiefel V, Nazy I, Lee LS, Sachs U, Warkentin TE, Greinacher A | 2019 | J Thromb Haemost | View An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia | Researchers | New or improved product or process |
Anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Anti-Lewis | Health care providers | Clinical research |
Laboratory diagnosis of heparin-induced thrombocytopenia | Warkentin TE | 2019 | Int J Lab Hematol | View Laboratory diagnosis of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Atreya C, Glynn S, Busch M, Kleinman S, Snyder E, Rutter S, AuBuchon J, Flegel W, Reeve D, Devine D, Cohn C, Custer B, Goodrich R, Benjamin RJ, Razatos A, Cancelas J, Wagner S, Maclean M, Gelderman M, Cap A, Ness P | 2019 | Transfusion | View Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Researchers | New or improved product or process |
Système Rhésus : l’anticorps anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-V | Health care providers | Benchmarking and standard setting |
Vein to Vein: A Summary of the Blood System in Canada | Chargé S | 2019 | Clinical Guide to Transfusion | View Vein to Vein: A Summary of the Blood System in Canada | Health care providers | Benchmarking and standard setting |
Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank | Haw J, Polzer J, Devine DV | 2019 | Transfusion | View Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank | Researchers | New or improved product or process |
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation | Iba T, Levy JH, Raj A, Warkentin TE | 2019 | J Clin Med | View Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation | Health care providers | Clinical research |
Cryoprotection of platelets by grafted polymers | Scott M, Nakane N, Maurer-Spurej E | 2019 | Cryopreservation - Current Advances and Evaluations | View Cryoprotection of platelets by grafted polymers | Researchers | Basic research |
HIV Risk Factors | Goldman M | 2019 | Screening Blood Donors with the Donor History Questionnaire | View HIV Risk Factors | Blood operators | Benchmarking and standard setting |
Rh System: Anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-Cw | Health care providers | Benchmarking and standard setting |
Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-?TP-L309C, a recombinant IgG1 Fc hexamer | Lewis BJB, Ville J, Blacquiere M, Cen S, Spirig R, Zuercher AW, Käsermann F, Branch DR | 2019 | BMC Immunol | View Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-?TP-L309C, a recombinant IgG1 Fc hexamer | Researchers | Basic research |
Trombocitopenia Fetal/Neonatal Aloinmune (TFNA): Informacion para el paciente | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Trombocitopenia Fetal/Neonatal Aloinmune (TFNA): Informacion para el paciente | Other | Other |
Group AB cryoprecipitate hospital practices | Romans R | 2019 | Blood.ca website | View Group AB cryoprecipitate hospital practices | Health care providers | Benchmarking and standard setting |
Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients | Warkentin TE | 2019 | Hämostaseologie | View Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients | Researchers | Clinical research |
Canadian Blood Services should screen for behaviour, not sexual orientation | Lachowsky NJ, Grace D | 2019 | Georgia Straight | View Canadian Blood Services should screen for behaviour, not sexual orientation | Other | Other |
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial | Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussieres J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K, FIBRES Research Group | 2019 | JAMA | View Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial | Health care providers | Clinical research |
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon M-C, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS | 2018 | Lancet Haematol | View Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Health care providers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | McEneny-King A, Chelle P, Iorio A, Edginton AN | 2018 | Thromb Res | View The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | Health care providers | Clinical research |
A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting | Sirianni G, Perri G, Callum J, Gardner S, Berall A, Selby D | 2018 | Am J Hosp Palliat Care | View A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting | Researchers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Researchers | Basic research |
Concentré de recherche: Vers une uniformisation des politiques d'exclusion du don de sang et de plasma | Goldman M, O'Brien S, Devine D | 2018 | Blood.ca website | View Concentré de recherche: Vers une uniformisation des politiques d'exclusion du don de sang et de plasma | Researchers | Basic research |
Signalement des réactions transfusionnelles indésirables | Chargé S, Young D | 2018 | Blood.ca website | View Signalement des réactions transfusionnelles indésirables | Health care providers | Other |
Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay | Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, Duong TT, Yeung RSM, Binnington B, Branch DR, Acker JP, Holovati JL | 2018 | Transfusion | View Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay | Researchers | Basic research |
Concentré de recherche: Important rôle de la GPIba, une protéine plaquettaire, dans la régulation de la production hépatique de thrombopoiétine | Ni H | 2018 | Blood.ca website | View Concentré de recherche: Important rôle de la GPIba, une protéine plaquettaire, dans la régulation de la production hépatique de thrombopoiétine | Other | Other |
Concentrates for Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Concentrates for Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) | Turley E, McGowan EC, Hyland CA, Schoeman EM, Flower RL, Skoll A, Delisle MF, Nelson T, Clarke G, Au N | 2018 | Transfusion | View Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) | Researchers | Clinical research |
Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists | Bennett S, Ayoub A, Tran A, English S, Tinmouth A, McIsaac DI, Fergusson D, Martel G | 2018 | Transfusion | View Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists | Health care providers | Clinical research |
Impact of blood manufacturing and donor characteristics on membrane water permeability and in vitro quality parameters during hypothermic storage of red blood cells | Alshalani A, Howell A, Acker JP | 2018 | Cryobiology | View Impact of blood manufacturing and donor characteristics on membrane water permeability and in vitro quality parameters during hypothermic storage of red blood cells | Researchers | Basic research |
Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Cohen R, Ning S, Yan MTS, Callum J | 2018 | Transfus Med Rev | View Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Health care providers | Clinical research |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J | 2018 | Res Pract Thromb Haem | View Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Health care providers | Clinical research |
Hommes gais et don de sang : Un projet à l'étude | Otis J, Caruso J | 2018 | Fugues | View Hommes gais et don de sang : Un projet à l'étude | Other | Other |
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay | Warkentin TE, Arnold DM, Kelton JG, Sheppard J-AI, Smith JW, Nazy I | 2018 | Chest | View Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay | Researchers | Basic research |
MicroRNA-218-5p Promotes Endovascular Trophoblast Differentiation and Spiral Artery Remodeling | Brki J, Dunk C, O'Brien J, Fu G, Nadeem L, Wang Y-l, Rosman D, Salem M, Shynlova O, Yougbare I, Ni H, Lye SJ, Peng C | 2018 | Mol Ther | View MicroRNA-218-5p Promotes Endovascular Trophoblast Differentiation and Spiral Artery Remodeling | Researchers | Basic research |
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Gantioqui J, Stevic I, Atkinson H, Chan AKC | 2018 | Blood Coagul Fibrinolysis | View Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Researchers | Basic research |
Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey | Kahale LA, Diab B, Brignardello-Petersen R, Agarwal A, Mustafa RA, Kwong J, Neumann I, Li L, Lopes LC, Briel M, Busse JW, Iorio A, Vandvik PO, Alexander PE, Guyatt G, Akl EA | 2018 | J Clin Epidemiol | View Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey | Researchers | Other |
Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis | Menchetti I, Lin Y, Cserti-Gazdewich C, Goldstein J, Law C, Lazarus A, Callum JL | 2018 | Transfusion | View Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis | Researchers | Clinical research |
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Spaner DE, Venema R, Huang J, Norris P, Lazarus A, Wang G, Shi Y | 2018 | EBioMedicine | View Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Health care providers | Clinical research |
Platelet immunobiology: platelets as prey and predator | Kapur R, Semple JW | 2018 | ISBT Sci Ser | View Platelet immunobiology: platelets as prey and predator | Researchers | Basic research |
Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Garg AX, Shehata N, McGuinness S, Whitlock R, Fergusson D, Wald R, Parikh C, Bagshaw SM, Khanykin B, Gregory A, Syed S, Hare GMT, Cuerden MS, Thorpe KE, Hall J, Verma S, Roshanov PS, Sontrop JM, Mazer CD | 2018 | Can J Kidney Health Dis | View Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Researchers | Clinical research |
Adverse reactions reporting | Chargé S, Young D | 2018 | Blood.ca website | View Adverse reactions reporting | Health care providers | Other |
Initial flow cytometric evaluation of the Clearllab lymphoid screen | Hedley BD, Cheng G, Luider J, Kern W, Lozanski G, Chin-Yee I, Lowes LE, Keeney M, Careaga D, Magari R, Tejidor L | 2018 | Cytometry B Clin Cytom | View Initial flow cytometric evaluation of the Clearllab lymphoid screen | Researchers | Basic research |
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines | 2018 | Vox Sang | View Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Researchers | Clinical research |
Clinical Outcomes and Red Blood Cell Storage | Ning S, Heddle NM | 2018 | Hematologic Challenges in the Critically Ill | View Clinical Outcomes and Red Blood Cell Storage | Other | Other |
Les concentrés de facteurs de coagulation | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Les concentrés de facteurs de coagulation | Health care providers | Other |
Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs J-LH | 2018 | Blood | View Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | Researchers | Clinical research |